Literature DB >> 11089603

Surgeon influenced variables in resectional rectal cancer surgery.

S D Wexner1, N A Rotholtz.   

Abstract

PURPOSE: Surgeon influenced variables in rectal cancer surgery were assessed.
METHODS: The literature was reviewed to discuss technical and educational issues that may affect the outcome of surgery for rectal cancer. Particular attention was paid to recently debated topics such as adjuvant therapy, colonic J-pouches, total mesorectal excision, and surgeons' training.
RESULTS: In some selected cases, transanal techniques with or without neoadjuvant or adjuvant therapy have improved the success of local excision. The biology of rectal cancer has begun to be understood. However, until a more complete understanding with an appreciation of therapeutic implications has been arrived at, surgeon influenced variables will continue to be of paramount importance. Multiple studies have shown tremendous surgeon variability in the outcome after rectal cancer surgery. Some of the variables that have been shown to be important include tumor-free distal and lateral margins, a total mesorectal excision, and an appropriate anastomosis. It has been well demonstrated that proctectomy with straight coloanal anastomosis compromises function as compared with preoperative levels or healthy controls. These deficiencies are further exacerbated by adjuvant therapy. Significant functional improvements, particularly in the first 12 to 24 months after surgery, have been achieved with use of colonic J-pouch.
CONCLUSION: There are many ways by which the surgeon can optimize curative resection for rectal cancer. Appropriate distal and tumor-free lateral margins with total mesorectal excision should be the goals for all tumors in the lower two-thirds of the rectum. Reconstruction should be performed, whenever technically possible, by a colonic J-pouch. Surgeons should be cognizant of their own practice patterns, volume, capabilities, and very importantly results. These results should be audited frequently and willingly shared with patients.

Entities:  

Mesh:

Year:  2000        PMID: 11089603     DOI: 10.1007/BF02236751

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  21 in total

1.  The effect of the surgeon and the pathologist on patient survival after resection of colon and rectal cancer.

Authors:  James W Fleshman
Journal:  Ann Surg       Date:  2002-04       Impact factor: 12.969

2.  Laparoscopic total mesorectal excision of low rectal cancer with preservation of anal sphincter: a report of 82 cases.

Authors:  Zong-Guang Zhou; Zhao Wang; Yong-Yang Yu; Ye Shu; Zhong Cheng; Li Li; Wen-Zhang Lei; Tian-Cai Wang
Journal:  World J Gastroenterol       Date:  2003-07       Impact factor: 5.742

3.  Transanal total mesorectal excision (taTME) for rectal cancer: a training pathway.

Authors:  Elisabeth C McLemore; Christina R Harnsberger; Ryan C Broderick; Hyuma Leland; Patricia Sylla; Alisa M Coker; Hans F Fuchs; Garth R Jacobsen; Bryan Sandler; Vikram Attaluri; Anna T Tsay; Steven D Wexner; Mark A Talamini; Santiago Horgan
Journal:  Surg Endosc       Date:  2015-12-10       Impact factor: 4.584

Review 4.  Low anterior resection syndrome (LARS): cause and effect and reconstructive considerations.

Authors:  Y Ziv; A Zbar; Y Bar-Shavit; I Igov
Journal:  Tech Coloproctol       Date:  2012-10-18       Impact factor: 3.781

5.  Clinicopathologic and prognostic significance of matrix metalloproteinases in rectal cancer.

Authors:  O Schwandner; A Schlamp; R Broll; H P Bruch
Journal:  Int J Colorectal Dis       Date:  2006-08-02       Impact factor: 2.571

6.  High Rate of Positive Circumferential Resection Margins Following Rectal Cancer Surgery: A Call to Action.

Authors:  Aaron S Rickles; David W Dietz; George J Chang; Steven D Wexner; Mariana E Berho; Feza H Remzi; Frederick L Greene; James W Fleshman; Maher A Abbas; Walter Peters; Katia Noyes; John R T Monson; Fergal J Fleming
Journal:  Ann Surg       Date:  2015-12       Impact factor: 12.969

7.  Transanal TAMIS total mesorectal excision (TME)--a work in progress.

Authors:  S D Wexner; M Berho
Journal:  Tech Coloproctol       Date:  2014-03-29       Impact factor: 3.781

8.  Local excision carcinoma in early stage.

Authors:  Ji-Dong Gao; Yong-Fu Shao; Jian-Jun Bi; Su-Sheng Shi; Jun Liang; Yu-Hua Hu
Journal:  World J Gastroenterol       Date:  2003-04       Impact factor: 5.742

9.  The investigation of primary rectal cancer by surgeons: current pattern of practice.

Authors:  Todd P W McMullen; Alexandra M Easson; Zane Cohen; Carol J Swallow
Journal:  Can J Surg       Date:  2005-02       Impact factor: 2.089

10.  Comparative evaluation of immune response after laparoscopical and open total mesorectal excisions with anal sphincter preservation in patients with rectal cancer.

Authors:  Jian-Kun Hu; Zong-Guang Zhou; Zhi-Xin Chen; Lan-Lan Wang; Yong-Yang Yu; Jin Liu; Bo Zhang; Li Li; Ye Shu; Jia-Ping Chen
Journal:  World J Gastroenterol       Date:  2003-12       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.